Aldeyra Therapeutics Statistics
Total Valuation
ALDX has a market cap or net worth of $312.65 million. The enterprise value is $258.14 million.
Important Dates
The last earnings date was Monday, March 2, 2026, after market close.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALDX has 60.18 million shares outstanding. The number of shares has increased by 0.96% in one year.
| Current Share Class | 60.18M |
| Shares Outstanding | 60.18M |
| Shares Change (YoY) | +0.96% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 3.14% |
| Owned by Institutions (%) | 53.59% |
| Float | 48.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.32 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.06 |
| P/TBV Ratio | 7.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.58 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.51 |
Financial Efficiency
Return on equity (ROE) is -58.73% and return on invested capital (ROIC) is -30.17%.
| Return on Equity (ROE) | -58.73% |
| Return on Assets (ROA) | -24.95% |
| Return on Invested Capital (ROIC) | -30.17% |
| Return on Capital Employed (ROCE) | -79.69% |
| Weighted Average Cost of Capital (WACC) | 9.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.23M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.27% in the last 52 weeks. The beta is 0.99, so ALDX's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -14.27% |
| 50-Day Moving Average | 5.04 |
| 200-Day Moving Average | 4.78 |
| Relative Strength Index (RSI) | 49.48 |
| Average Volume (20 Days) | 795,340 |
Short Selling Information
The latest short interest is 5.47 million, so 9.10% of the outstanding shares have been sold short.
| Short Interest | 5.47M |
| Short Previous Month | 5.25M |
| Short % of Shares Out | 9.10% |
| Short % of Float | 11.26% |
| Short Ratio (days to cover) | 6.78 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -35.27M |
| Pretax Income | -33.85M |
| Net Income | -33.85M |
| EBITDA | -35.01M |
| EBIT | -35.27M |
| Earnings Per Share (EPS) | -$0.56 |
Full Income Statement Balance Sheet
The company has $70.04 million in cash and $15.53 million in debt, with a net cash position of $54.51 million or $0.91 per share.
| Cash & Cash Equivalents | 70.04M |
| Total Debt | 15.53M |
| Net Cash | 54.51M |
| Net Cash Per Share | $0.91 |
| Equity (Book Value) | 44.25M |
| Book Value Per Share | 0.74 |
| Working Capital | 43.97M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -33.35M |
| Capital Expenditures | n/a |
| Free Cash Flow | -33.35M |
| FCF Per Share | -$0.55 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.96% |
| Shareholder Yield | -0.96% |
| Earnings Yield | -10.83% |
| FCF Yield | -10.67% |
Analyst Forecast
The average price target for ALDX is $9.50, which is 82.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.50 |
| Price Target Difference | 82.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |